Medicamen Biotech Limited (BOM:531146)

Market Cap	4.45B -25.4%
Revenue (ttm)	1.70B -6.4%
Net Income	90.53M +19.7%
EPS	7.45 +41.7%
Shares Out	12.71M
PE Ratio	46.94
Forward PE	n/a
Dividend	1.00 (0.29%)
Ex-Dividend Date	Sep 19, 2025

Volume	390
Average Volume	1,064
Open	343.85
Previous Close	351.10
Day's Range	339.00 - 347.65
52-Week Range	292.50 - 560.00
Beta	0.46
RSI	43.61
Earnings Date	Feb 13, 2026

About Medicamen Biotech

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi,...

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Employees: 376
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531146

Financial Performance

In fiscal year 2025, Medicamen Biotech's revenue was 1.68 billion, a decrease of -6.56% compared to the previous year's 1.79 billion. Earnings were 71.08 million, a decrease of -34.97%.